Rapid Communication
Copyright ©2008 The WJG Press and Baishideng.
World J Gastroenterol. Apr 28, 2008; 14(16): 2529-2533
Published online Apr 28, 2008. doi: 10.3748/wjg.14.2529
Table 1 Number of spots in IFN-γ and IL-4 ELISPOT assays for all individuals (n)
nMean anti-HBsAg titer (IU/L)IFN-g response (# of spots)
IL-4 response (# of spots)
HBsAgTT AgHBsAgTT Ag
Non-responders130 ± 01.0 ± 1.39.1 ± 4.3 (6)0.2 ± 0.33.5 ± 3.9 (6)
Low-responders1236 ± 161.7 ± 2.67.8 ± 6.5 (7)0.5 ± 1.06.2 ± 10.1 (4)
High-responders17> 10005.4 ± 5.19.1 ± 6.21.0 ± 2.11.7 ± 3.9 (13)
Vaccines before 1st vx120 ± 0 (9)4.5 ± 5.711.2 ± 7.3 (11)0.3 ± 0.5 (9)4.5 ± 4.9 (5)
Vaccines after 3rd vx1210 × > 1000, 1 × 211, 1 × 3947.1 ± 6.210.0 ± 8.42.7 ± 5.63.0 ± 4.4 (8)